Acute modification in plasma lipid levels in ultramarathon runners

References

• Benı́tez, S., Sánchez-Quesada, J. L., Lucero, L., Arcelus, R., Ribas, V., Jorba, O., … Ordóñez-Llanos, J. (2002). Changes in low-density lipoprotein electronegativity and oxidizability after aerobic exercise are related to the increase in associated non-esterified fatty acids. Atherosclerosis, 160, 223–232.
   PubMed Web of Science ®Google Scholar
• Berlin, J. A., & Colditz, G. A. (1990). A meta-analysis of physical activity in the prevention of coronary heart disease. American Journal of Epidemiology, 132, 612–628.
   PubMed Web of Science ®Google Scholar
• Chait, A., Brazg, R. L., Tribble, D. L., & Krauss, R. M. (1993). Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. The American Journal of Medicine, 94, 350–356.
   PubMed Web of Science ®Google Scholar
• Chan, D. C., & Watts, G. F. (2006). Apolipoproteins as markers and managers of coronary risk. QJM: Monthly Journal of the Association of Physicians, 99, 277–287.
   PubMed Web of Science ®Google Scholar
• Davies, K. J. A., Quintanilha, A. T., Brooks, G. A., & Packer, L. (1982). Free radicals and tissue damage produced by exercise. Biochemical and Biophysical Research Communications, 107, 1198–1205.
   PubMed Web of Science ®Google Scholar
• Davis, P. G., Bartoli, W. P., & Durstine, J. L. (1992). Effects of acute exercise intensity on plasma lipids and apolipoproteins in trained runners. Journal of Applied Physiology, 72, 914–919.
   PubMed Web of Science ®Google Scholar
• El-Sayed, M. S. (1996). Effects of exercise on blood coagulation, fibrinolysis and platelet aggregation. Sports Medicine, 22, 282–298.
   PubMed Web of Science ®Google Scholar
• Ernst, E., & Resch, K. L. (1995). Therapeutic interventions to lower plasma fibrinogen concentration. European Heart Journal, 16, 47–53, discussion 52-43.
   PubMed Web of Science ®Google Scholar
• Fallon, K. E. (2001). The acute phase response and exercise: The ultramarathon as prototype exercise. Clinical Journal of Sport Medicine, 11, 38–43.
   PubMed Web of Science ®Google Scholar
• Hardin, D. S., Azzarelli, B., Edwards, J., Wigglesworth, J., Maianu, L., Brechtel, G., & Garvey, W. T. (1995). Mechanisms of enhanced insulin sensitivity in endurance-trained athletes: Effects on blood flow and differential expression of GLUT 4 in skeletal muscles. Journal of Clinical Endocrinology & Metabolism, 80, 2437–2446.
   PubMed Web of Science ®Google Scholar
• Hulthe, J., Bokemark, L., Wikstrand, J., & Fagerberg, B. (2000). The metabolic syndrome, LDL particle size, and atherosclerosis: The Atherosclerosis and Insulin Resistance (AIR) study. Arteriosclerosis, Thrombosis and Vascular Biology, 20, 2140–2147.
   PubMed Web of Science ®Google Scholar
• Jungner, I., Sniderman, A. D., Furberg, C., Aastveit, A. H., Holme, I., & Walldius, G. (2006). Does low-density lipoprotein size add to atherogenic particle number in predicting the risk of fatal myocardial infarction? The American Journal of Cardiology, 97, 943–946.
   PubMed Web of Science ®Google Scholar
• Kantor, M. A., Cullinane, E. M., Herbert, P. N., & Thompson, P. D. (1984). Acute increase in lipoprotein lipase following prolonged exercise. Metabolism, 33, 454–457.
   PubMed Web of Science ®Google Scholar
• Lamarche, B., Tchernof, A., Moorjani, S., Cantin, B., Dagenais, G. R., Lupien, P. J., & Despres, J.-P. (1997). Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men: Prospective results from the Quebec Cardiovascular Study. Circulation, 95, 69–75.
   PubMed Web of Science ®Google Scholar
• Lamon-Fava, S., McNamara, J. R., Farber, H. W., Hill, N. S., & Schaefer, E. J. (1989). Acute changes in lipid, lipoprotein, apolipoprotein, and low-density lipoprotein particle size after an endurance triathlon. Metabolism, 38, 921–925.
   PubMed Web of Science ®Google Scholar
• Liu, M. L., Bergholm, R., Mäkimattila, S., Lahdenperä, S., Valkonen, M., Hilden, H., & Taskinen, M. R. (1999). A marathon run increases the susceptibility of LDL to oxidation in vitro and modifies plasma antioxidants. American Journal of Physiology, 276, E1083–E1091.
   PubMed Web of Science ®Google Scholar
• Magkos, F., Wright, D. C., Patterson, B. W., Mohammed, B. S., & Mittendorfer, B. (2006). Lipid metabolism response to a single, prolonged bout of endurance exercise in healthy young men. American Journal of Physiology Endocrinology and Metabolism, 290, E355–E362.
   PubMed Web of Science ®Google Scholar
• Margeli, A., Skenderi, K., Tsironi, M., Hantzi, E., Matalas, A.-L., Vrettou, C., … Papassotiriou, I. (2005). Dramatic elevations of interleukin-6 and acute-phase reactants in athletes participating in the ultradistance foot race spartathlon: Severe systemic inflammation and lipid and lipoprotein changes in protracted exercise. The Journal of Clinical Endocrinology & Metabolism, 90, 3914–3918.
   PubMed Web of Science ®Google Scholar
• Maron, B. J., & Zipes, D. P. (2005). Introduction: Eligibility recommendations for competitive athletes with cardiovascular abnormalities-general considerations. Journal of the American College of Cardiology, 45, 1318–1321.
   PubMed Web of Science ®Google Scholar
• McQueen, M. J., Hawken, S., Wang, X., Ounpuu, S., Sniderman, A., Probstfield, J., … Yusuf, S. (2008). Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): A case-control study. The Lancet, 372, 224–233.
   PubMed Web of Science ®Google Scholar
• Mello, A. P., da Silva, I. T., Abdalla, D. S., & Damasceno, N. R. (2011). Electronegative low-density lipoprotein: Origin and impact on health and disease. Atherosclerosis, 215, 257–265.
   PubMed Web of Science ®Google Scholar
• Nagel, D., Seiler, D., Franz, H., Leitzmann, C., & Jung, K. (1989). Effects of an ultra-long-distance (1000 km) race on lipid metabolism. European Journal of Applied Physiology and Occupational Physiology, 59, 16–20.
   PubMed Web of Science ®Google Scholar
• Ostrowski, K., Rohde, T., Zacho, M., Asp, S., & Pedersen, B. K. (1998). Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running. The Journal of Physiology, 508(3), 949–953.
   PubMed Web of Science ®Google Scholar
• Packard, C. J., & Shepherd, J. (1997). Lipoprotein heterogeneity and apolipoprotein B metabolism. Arteriosclerosis, Thrombosis and Vascular Biology, 17, 3542–3556.
   PubMed Web of Science ®Google Scholar
• Passaglia, D. G., Emed, L. G., Barberato, S. H., Guerios, S. T., Moser, A. I., Silva, M. M., & Faria-Neto, J. R. (2012). Acute effects of prolonged physical exercise: Evaluation after a twenty-four-hour ultramarathon. Arquivos Brasileiros de Cardiologia, 100(1), 21–28.
   PubMed Web of Science ®Google Scholar
• Pedersen, B. K. (2000). Special feature for the Olympics: Effects of exercise on the immune system: Exercise and cytokines. Immunology and Cell Biology, 78, 532–535.
   PubMed Web of Science ®Google Scholar
• Petibois, C., Paiva, M., Cazorla, G., & Déléris, G. (2002). Discriminant serum biochemical parameters in top class marathon performances. The Japanese Journal of Physiology, 52, 181–190.
   PubMedGoogle Scholar
• Sánchez-Quesada, J. L., Homs-Serradesanferm, R., Serrat-Serrat, J., Serra-Grima, J. R., González-Sastre, F., & Ordóñez-Llanos, J. (1995). Increase of LDL susceptibility to oxidation occurring after intense, long duration aerobic exercise. Atherosclerosis, 118, 297–305.
   PubMed Web of Science ®Google Scholar
• Sánchez-Quesada, J. L., Ortega, H., Payes-Romero, A., Serrat-Serrat, J., González-Sastre, F., Lasuncion, M. A., & Ordóñez-Llanos, J. (1997). LDL from aerobically-trained subjects shows higher resistance to oxidative modification than LDL from sedentary subjects. Atherosclerosis, 132, 207–213.
   PubMed Web of Science ®Google Scholar
• Shern-Brewer, R., Santanam, N., Wetzstein, C., White-Welkley, J., & Parthasarathy, S. (1998). Exercise and cardiovascular disease: A new perspective. Arteriosclerosis, Thrombosis and Vascular Biology, 18, 1181–1187.
   PubMed Web of Science ®Google Scholar
• Sigurdardottir, V., Fagerberg, B., & Hulthe, J. (2002). Circulating oxidized low-density lipoprotein (LDL) is associated with risk factors of the metabolic syndrome and LDL size in clinically healthy 58-year-old men (AIR study). Journal of Internal Medicine, 252, 440–447.
   PubMed Web of Science ®Google Scholar
• Skinner, E. R., Watt, C., & Maughan, R. J. (1987). The acute effect of marathon running on plasma lipoproteins in female subjects. European Journal of Applied Physiology and Occupational Physiology, 56, 451–456.
   PubMed Web of Science ®Google Scholar
• Sniderman, A. D., Furberg, C. D., Keech, A., Roeters Van Lennep, J. R., Frohlich, J., Jungner, I., & Walldius, G. (2003). Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment. The Lancet, 361, 777–780.
   PubMed Web of Science ®Google Scholar
• Sniderman, A. D., St-Pierre, A. C., Cantin, B., Dagenais, G. R., Després, J.-P., & Lamarche, B. (2003). Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk. The American Journal of Cardiology, 91, 1173–1177.
   PubMed Web of Science ®Google Scholar
• Wagner, A. M., Jorba, O., Rigla, M., Alonso, E., Ordonez-Llanos, J., & Perez, A. (2002). LDL-cholesterol/apolipoprotein B ratio is a good predictor of LDL phenotype B in type 2 diabetes. Acta Diabetologica, 39, 215–220.
   PubMed Web of Science ®Google Scholar
• Walldius, G., Jungner, I., Kolar, W., Holme, I., & Steiner, E. (1992). High cholesterol and triglyceride values in Swedish males and females: Increased risk of fatal myocardial infarction. First report from the AMORIS (Apolipoprotein related MOrtality RISk) study. Blood Pressure, 4(Suppl. 2), 35–42.
   Google Scholar
• Weintraub, M. S., Rosen, Y., Otto, R., Eisenberg, S., & Breslow, J. L. (1989). Physical exercise conditioning in the absence of weight loss reduces fasting and postprandial triglyceride-rich lipoprotein levels. Circulation, 79, 1007–1014.
   PubMed Web of Science ®Google Scholar
• Witztum, J. L. (1994). The oxidation hypothesis of atherosclerosis. The Lancet, 344, 793–795.
   PubMed Web of Science ®Google Scholar
• Wu, H. J., Chen, K. T., Shee, B. W., Chang, H. C., Huang, Y. J., & Yang, R. S. (2004). Effects of 24 h ultra-marathon on biochemical and hematological parameters. World Journal of Gastroenterology, 10, 2711–2714.
   PubMed Web of Science ®Google Scholar
• Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., … Lisheng, L. (2004). Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. The Lancet, 364, 937–952.
   PubMed Web of Science ®Google Scholar